Our Management Team
John F. Vavricka
John Vavricka brings to Iroko over 20 years of broad international experience in the pharmaceutical industry and a demonstrated capacity to build high-performing organizations. Since John co-founded Iroko in 2007, the company has assembled a workforce led by a seasoned management cadre...
read more
Olalekan Andrew Bayode
Olalekan Andrew Bayode has over 17 years of worldwide commercial experience. At Wyeth Pharmaceuticals (now Pfizer Inc), he was Commercial Director, Europe/Middle East/Africa/Canada, in the Pharmaceutical Global Business Unit. He also served as Commercial Director for the rheumatology ...
read more
Humphrey J. Harte
Humphrey Harte has more than 20 years of sales and marketing experience in both established and start-up companies in various countries. He was Vice-President, Commercial Operations, Europe and General Manager UK, at Novartis Vaccines. Prior to this he was a member of the Senior...
read more
Paul Hemsley
Paul Hemsley has more than 20 years of experience in pharmaceutical companies and consulting firms. He was Vice President, Global Strategic Planning, and Vice President, Marketing, at Novartis (formerly Chiron) Vaccines. Earlier, as a management consultant, he advised life-sciences companies on commercial and R&D strategy...
read more
E. Olaolu Imasogie MD
Olaolu Imasogie has more than 20 years of experience in medicine, information technology, and the pharmaceutical industry.At GlaxoSmithKline he designed continuing-medical-education programs for the metabolic therapeutic area and worked in Medical Information and Medical Affairs. Earlier, he served as...
read more
Moji James
Moji James has two decades of experience as an attorney, during which time she has supported the development and launch of high-profile drugs, biologics and vaccines. At Iroko, she has overall responsibility for the legal, human resources and compliance functions.
read more
Steve Jensen
Steve Jensen is a senior regulatory professional with nearly 20 years of industry experience leading U.S. and international development and post-marketing programs. He was a principal advisor and a co-founder at Laurus Regulatory Advisors, a pharma/biotech consulting firm specializing...
read more
Fred C. Krieger
Fred Krieger has more than 30 years of experience managing a wide array of financial functions in international pharmaceutical companies. He served as Vice President, Financial Control, Planning and Reporting, at GlaxoSmithKline Pharmaceuticals Research & Development. There he directed...
read more
Ariyapadi N. Krishnaraj
Ariyapadi Krishnaraj has more than 20 years of sales and marketing experience in the pharmaceutical industry.He was Senior Vice President, Healthcare Analytics, for Genpact, Inc. There he led the building of the analytics-services business while serving such clients as GlaxoSmithKline, Pfizer, Johnson and Johnson...
read more
Rohit C. Mehta
Rohit Mehta has nearly 20 years of experience across a broad range of business-development activities, including licensing, product acquisitions, M&A due diligence, joint ventures, and technology assessment. He was a principal in Jay Consulting, a firm providing business and...
read more
Clarence L. Young, M.D.
Dr. Clarence L. Young has nearly 25 years of drug development and research experience from the pharmaceutical industry as well as academia. Over the course of his career he has provided medical oversight of numerous clinical trials, regulatory filings, and product launches.
Prior to joining Iroko, he was Vice President Targeted Therapies and Integrated Hospital Care at Novartis Pharmaceuticals Corporation, responsible for leading cross-functional teams in development, global registration and commercialization of small and large molecules.
read more